ACCELERON PHARMA INC Insider Trading for January 2019

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in ACCELERON PHARMA INC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of insider trading in ACCELERON PHARMA INC for January 2019.

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jan 29 2019	XLRN	ACCELERON PHARMA I ...	Zakrzewski Joseph S	Director	Option Exercise	A	41.64	7,500	312,300	7,500
Jan 29 2019	XLRN	ACCELERON PHARMA I ...	Zakrzewski Joseph S	Director	Grant	A	0.00	1,250	0	7,750	6.5 K to 7.8 K (+19.23 %)
Jan 29 2019	XLRN	ACCELERON PHARMA I ...	Smith Karen L.	Director	Option Exercise	A	41.64	7,500	312,300	7,500
Jan 29 2019	XLRN	ACCELERON PHARMA I ...	Smith Karen L.	Director	Grant	A	0.00	1,250	0	1,562	312 to 1.6 K (+400.64 %)
Jan 29 2019	XLRN	ACCELERON PHARMA I ...	POPS RICHARD F	Director	Option Exercise	A	41.64	7,500	312,300	7,500
Jan 29 2019	XLRN	ACCELERON PHARMA I ...	POPS RICHARD F	Director	Grant	A	0.00	1,250	0	32,500	31.3 K to 32.5 K (+4.00 %)
Jan 29 2019	XLRN	ACCELERON PHARMA I ...	MCCOURT Thomas A	Director	Option Exercise	A	41.64	7,500	312,300	7,500
Jan 29 2019	XLRN	ACCELERON PHARMA I ...	MCCOURT Thomas A	Director	Grant	A	0.00	1,250	0	3,045	1.8 K to 3 K (+69.64 %)
Jan 29 2019	XLRN	ACCELERON PHARMA I ...	Maniatis Tom	Director	Option Exercise	A	41.64	7,500	312,300	7,500
Jan 29 2019	XLRN	ACCELERON PHARMA I ...	Maniatis Tom	Director	Grant	A	0.00	1,250	0	136,731	135.5 K to 136.7 K (+0.92 %)
Jan 29 2019	XLRN	ACCELERON PHARMA I ...	Kearney Terrence C	Director	Option Exercise	A	41.64	7,500	312,300	7,500
Jan 29 2019	XLRN	ACCELERON PHARMA I ...	Kearney Terrence C	Director	Grant	A	0.00	1,250	0	3,750	2.5 K to 3.8 K (+50.00 %)
Jan 29 2019	XLRN	ACCELERON PHARMA I ...	George Jean	Director	Option Exercise	A	41.64	7,500	312,300	7,500
Jan 29 2019	XLRN	ACCELERON PHARMA I ...	George Jean	Director	Grant	A	0.00	1,250	0	3,750	2.5 K to 3.8 K (+50.00 %)
Jan 29 2019	XLRN	ACCELERON PHARMA I ...	Nader Francois	Director	Option Exercise	A	41.64	7,500	312,300	7,500
Jan 29 2019	XLRN	ACCELERON PHARMA I ...	Nader Francois	Director	Grant	A	0.00	1,250	0	3,750	2.5 K to 3.8 K (+50.00 %)
Jan 29 2019	XLRN	ACCELERON PHARMA I ...	Kumar Ravindra	SVP & Chief Scienti ...	Option Exercise	A	41.64	21,500	895,260	21,500
Jan 29 2019	XLRN	ACCELERON PHARMA I ...	Kumar Ravindra	SVP & Chief Scienti ...	Grant	A	0.00	3,850	0	93,997	90.1 K to 94 K (+4.27 %)
Jan 29 2019	XLRN	ACCELERON PHARMA I ...	KANGO SUJAY	SVP, Chief Commerci ...	Option Exercise	A	41.64	25,500	1,061,820	25,500
Jan 29 2019	XLRN	ACCELERON PHARMA I ...	KANGO SUJAY	SVP, Chief Commerci ...	Grant	A	0.00	4,050	0	10,050	6 K to 10.1 K (+67.50 %)
Jan 29 2019	XLRN	ACCELERON PHARMA I ...	Quisel John D	EVP, CBO and Secret ...	Option Exercise	A	41.64	28,500	1,186,740	28,500
Jan 29 2019	XLRN	ACCELERON PHARMA I ...	Quisel John D	EVP, CBO and Secret ...	Grant	A	0.00	4,800	0	57,456	52.7 K to 57.5 K (+9.12 %)
Jan 29 2019	XLRN	ACCELERON PHARMA I ...	Zeldin Robert K	EVP & Chief Medical ...	Option Exercise	A	41.64	13,000	541,320	13,000
Jan 29 2019	XLRN	ACCELERON PHARMA I ...	Zeldin Robert K	EVP & Chief Medical ...	Grant	A	0.00	2,200	0	19,103	16.9 K to 19.1 K (+13.02 %)
Jan 29 2019	XLRN	ACCELERON PHARMA I ...	MCLAUGHLIN KEVIN F	SVP, CFO and Treasu ...	Option Exercise	A	41.64	28,000	1,165,920	28,000
Jan 29 2019	XLRN	ACCELERON PHARMA I ...	MCLAUGHLIN KEVIN F	SVP, CFO and Treasu ...	Grant	A	0.00	4,700	0	42,927	38.2 K to 42.9 K (+12.29 %)
Jan 29 2019	XLRN	ACCELERON PHARMA I ...	Dable Habib J	CEO and President	Option Exercise	A	41.64	106,400	4,430,496	106,400
Jan 29 2019	XLRN	ACCELERON PHARMA I ...	Dable Habib J	CEO and President	Grant	A	0.00	17,700	0	83,968	66.3 K to 84 K (+26.71 %)
Jan 22 2019	XLRN	ACCELERON PHARMA I ...	CELGENE CORP /DE/		Buy	P	43.00	706,206	30,366,858	6,824,685	6.1 M to 6.8 M (+11.54 %)
Jan 04 2019	XLRN	ACCELERON PHARMA I ...	Kumar Ravindra	SVP & Chief Scienti ...	Sell	S	43.94	374	16,434	90,147	90.5 K to 90.1 K (-0.41 %)
Jan 04 2019	XLRN	ACCELERON PHARMA I ...	Kumar Ravindra	SVP & Chief Scienti ...	Sell	S	43.20	3,051	131,803	90,521	93.6 K to 90.5 K (-3.26 %)
Jan 04 2019	XLRN	ACCELERON PHARMA I ...	Kumar Ravindra	SVP & Chief Scienti ...	Sell	S	42.45	2,363	100,309	93,572	95.9 K to 93.6 K (-2.46 %)
Jan 04 2019	XLRN	ACCELERON PHARMA I ...	Quisel John D	EVP, CBO and Secret ...	Sell	S	43.92	475	20,862	52,656	53.1 K to 52.7 K (-0.89 %)
Jan 04 2019	XLRN	ACCELERON PHARMA I ...	Quisel John D	EVP, CBO and Secret ...	Sell	S	43.10	2,558	110,250	53,131	55.7 K to 53.1 K (-4.59 %)
Jan 04 2019	XLRN	ACCELERON PHARMA I ...	Quisel John D	EVP, CBO and Secret ...	Sell	S	42.31	1,300	55,003	55,689	57 K to 55.7 K (-2.28 %)
Jan 04 2019	XLRN	ACCELERON PHARMA I ...	Quisel John D	EVP, CBO and Secret ...	Sell	S	43.26	300	12,978	56,989	57.3 K to 57 K (-0.52 %)
Jan 04 2019	XLRN	ACCELERON PHARMA I ...	Quisel John D	EVP, CBO and Secret ...	Sell	S	42.32	1,309	55,397	57,289	58.6 K to 57.3 K (-2.23 %)
Jan 04 2019	XLRN	ACCELERON PHARMA I ...	MCLAUGHLIN KEVIN F	SVP, CFO and Treasu ...	Sell	S	44.06	97	4,274	38,227	38.3 K to 38.2 K (-0.25 %)
Jan 04 2019	XLRN	ACCELERON PHARMA I ...	MCLAUGHLIN KEVIN F	SVP, CFO and Treasu ...	Sell	S	43.33	1,717	74,398	38,324	40 K to 38.3 K (-4.29 %)
Jan 04 2019	XLRN	ACCELERON PHARMA I ...	MCLAUGHLIN KEVIN F	SVP, CFO and Treasu ...	Sell	S	42.56	2,186	93,036	40,041	42.2 K to 40 K (-5.18 %)
Jan 04 2019	XLRN	ACCELERON PHARMA I ...	MCLAUGHLIN KEVIN F	SVP, CFO and Treasu ...	Sell	S	43.20	300	12,960	42,227	42.5 K to 42.2 K (-0.71 %)
Jan 04 2019	XLRN	ACCELERON PHARMA I ...	MCLAUGHLIN KEVIN F	SVP, CFO and Treasu ...	Sell	S	42.37	1,412	59,826	42,527	43.9 K to 42.5 K (-3.21 %)
Jan 04 2019	XLRN	ACCELERON PHARMA I ...	Dable Habib J	CEO and President	Sell	S	40.85	27	1,103	66,268	66.3 K to 66.3 K (-0.04 %)
Jan 04 2019	XLRN	ACCELERON PHARMA I ...	Dable Habib J	CEO and President	Sell	S	43.45	1,930	83,859	66,295	68.2 K to 66.3 K (-2.83 %)